KYMERA THERAPEUTICS, INC. (KYMR) /
The cash flow of KYMERA THERAPEUTICS, INC. over the past 7 years
Chart KYMERA THERAPEUTICS, INC.: operating cash flow, capital expenditures, free cash flow, fiscal 2019–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, KYMERA THERAPEUTICS, INC.'s operating cash flow was -$232.89M and its capital expenditures $1.45M, leaving free cash flow of -$234.34M. Free cash flow was above zero in 2 of the 7 years shown. It ranged from -$234.34M in fiscal 2025 to $79.03M in fiscal 2020. Capital expenditures were highest in fiscal 2023, at $34.48M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | -$232.89M | $1.45M | -$234.34M |
| 2024ended Dec 31, 2024 | -$194.5M | $12.84M | -$207.34M |
| 2023ended Dec 31, 2023 | -$102.83M | $34.48M | -$137.31M |
| 2022ended Dec 31, 2022 | -$153.09M | $2.84M | -$155.92M |
| 2021ended Dec 31, 2021 | -$128.95M | $1.6M | -$130.54M |
| 2020ended Dec 31, 2020 | $88.13M | $9.1M | $79.03M |
| 2019ended Dec 31, 2019 | $17.91M | $532K | $17.37M |
Fiscal years as KYMERA THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on KYMERA THERAPEUTICS, INC.
- The revenue of KYMERA THERAPEUTICS, INC.
- The profitability of KYMERA THERAPEUTICS, INC.
- The debt of KYMERA THERAPEUTICS, INC.
- All of KYMERA THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- DDSDILLARD’S, INC.
- HIIHUNTINGTON INGALLS INDUSTRIES, INC.
- ARWARROW ELECTRONICS, INC.
- FNFFIDELITY NATIONAL FINANCIAL, INC.
- BMRNBIOMARIN PHARMACEUTICAL INC
Not investment advice. This page shows what KYMERA THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.